Fabs
Fabs
to
Fabs's feed,
Quelli che la scienza la capisHAHAHA,
meanthebay presents: fun with vaccines,
Questioni di scienza
"A malaria vaccine capable of giving people 100% protection against the disease will be tested in a large clinical trial for the first time. The trial will begin in 2020 on Bioko, an island of Equatorial Guinea, and will involve 2,100 people, including children. The vaccine, called PfSPZ, is injected intravenously and works by eliciting an immune response against the malaria parasite Plasmodium falciparum. [...]" https://www.nature.com/ar...
"A malaria vaccine capable of giving people 100% protection against the disease will be tested in a large clinical trial for the first time. The trial will begin in 2020 on Bioko, an island of Equatorial Guinea, and will involve 2,100 people, including children. The vaccine, called PfSPZ, is injected intravenously and works by eliciting an immune response against the malaria parasite Plasmodium falciparum. [...]" https://www.nature.com/ar...
7 years ago
-
Comment
-
Hide
-
-
[ 0 ]
-
[ 0 ]
- (Edit | Remove)
- More...
"[...] It is made from sporozoites, which are a stage in the parasite’s life cycle that is transmitted by mosquitoes. Vaccine-maker Sanaria in Rockville, Maryland, produces the sporozoites from farmed mosquitoes. PfSPZ is the only malaria vaccine to have achieved 100% protection in laboratory trials with healthy volunteers. Equatorial Guinea’s government and private energy companies are sponsoring the trial."
-
Fabs
-
[ 0 ]
-
[ 0 ]
- (Edit | Remove)
